Grant C. Glatfelter

862 total citations
29 papers, 602 citations indexed

About

Grant C. Glatfelter is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Organic Chemistry. According to data from OpenAlex, Grant C. Glatfelter has authored 29 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 14 papers in Clinical Psychology and 11 papers in Organic Chemistry. Recurrent topics in Grant C. Glatfelter's work include Neurotransmitter Receptor Influence on Behavior (16 papers), Psychedelics and Drug Studies (14 papers) and Chemical synthesis and alkaloids (10 papers). Grant C. Glatfelter is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (16 papers), Psychedelics and Drug Studies (14 papers) and Chemical synthesis and alkaloids (10 papers). Grant C. Glatfelter collaborates with scholars based in United States, Belgium and Austria. Grant C. Glatfelter's co-authors include Michael H. Baumann, Donna Walther, Christophe P. Stove, Marthe M. Vandeputte, Margarita L. Dubocovich, Anthony Jones, John D. McCorvy, John S. Partilla, Tao Che and Olena Savych and has published in prestigious journals such as Nature, The FASEB Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Grant C. Glatfelter

27 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Grant C. Glatfelter United States	13	226	218	162	140	135	29	602
Cody J. Wenthur United States	17	426 1.9×	356 1.6×	95 0.6×	132 0.9×	79 0.6×	43	987
Henry Lowe Jamaica	13	159 0.7×	103 0.5×	172 1.1×	127 0.9×	34 0.3×	29	794
Tracy L. Swanson United States	12	169 0.7×	243 1.1×	108 0.7×	25 0.2×	157 1.2×	19	480
Davide Guerrieri Italy	15	253 1.1×	96 0.4×	52 0.3×	66 0.5×	168 1.2×	19	709
Katherine M. Wolfrum United States	10	162 0.7×	431 2.0×	319 2.0×	64 0.5×	361 2.7×	11	616
Lisa Wilson United States	21	478 2.1×	206 0.9×	55 0.3×	92 0.7×	210 1.6×	39	1.1k
Shridhar V. Andurkar United States	13	165 0.7×	98 0.4×	27 0.2×	156 1.1×	49 0.4×	30	609
Adeboye Adejare United States	14	236 1.0×	150 0.7×	48 0.3×	157 1.1×	67 0.5×	53	711
Marthe M. Vandeputte Belgium	15	211 0.9×	252 1.2×	73 0.5×	20 0.1×	343 2.5×	26	612
Annelies Cannaert Belgium	22	306 1.4×	611 2.8×	298 1.8×	54 0.4×	856 6.3×	35	1.2k

Countries citing papers authored by Grant C. Glatfelter

Since Specialization

Citations

This map shows the geographic impact of Grant C. Glatfelter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant C. Glatfelter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant C. Glatfelter more than expected).

Fields of papers citing papers by Grant C. Glatfelter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant C. Glatfelter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant C. Glatfelter. The network helps show where Grant C. Glatfelter may publish in the future.

Co-authorship network of co-authors of Grant C. Glatfelter

This figure shows the co-authorship network connecting the top 25 collaborators of Grant C. Glatfelter. A scholar is included among the top collaborators of Grant C. Glatfelter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant C. Glatfelter. Grant C. Glatfelter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Manke, David R., et al.. (2025). Development and validation of an analytical method for the determination of select 4-position ring-substituted tryptamines in plasma by liquid chromatography–tandem mass spectrometry. Journal of Analytical Toxicology. 49(6). 376–383.

Partilla, John S., et al.. (2025). Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice. Psychopharmacology. 242(10). 2249–2260. 2 indexed citations

Fogarty, Melissa F., Sara E. Walton, Grant C. Glatfelter, et al.. (2025). Toxicological evaluation, postmortem case descriptions, and pharmacological activity of N,N-dimethylpentylone and related analogs. Journal of Analytical Toxicology. 49(3). 143–151. 1 indexed citations

Vandeputte, Marthe M., Grant C. Glatfelter, Donna Walther, et al.. (2024). When a Prophecy Comes True: Ethyleneoxynitazene as a 'Prophetic' Member of the Emerging Class of 2-Benzylbenzimidazole 'Nitazene' Synthetic Opioids. Drug and Alcohol Dependence. 260. 109969–109969. 1 indexed citations

Glatfelter, Grant C., Eline Pottie, John S. Partilla, Christophe P. Stove, & Michael H. Baumann. (2024). Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited. ACS Pharmacology & Translational Science. 7(3). 641–653. 17 indexed citations

Glatfelter, Grant C., A. Clark, Antonio Landavazo, et al.. (2024). Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-N,N-dimethyltryptamine Analogs in Mice. ACS Chemical Neuroscience. 15(24). 4458–4477. 4 indexed citations

Vandeputte, Marthe M., Grant C. Glatfelter, Donna Walther, et al.. (2024). Characterization of novel nitazene recreational drugs: Insights into their risk potential from in vitro µ-opioid receptor assays and in vivo behavioral studies in mice. Pharmacological Research. 210. 107503–107503. 10 indexed citations

Glatfelter, Grant C., et al.. (2024). Reinforcing effects of fentanyl analogs found in illicit drug markets. Psychopharmacology. 241(11). 2375–2383. 3 indexed citations

Levinstein, Marjorie R., Paulo Alexandre de Oliveira, César Quiroz, et al.. (2023). Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone. Molecular Psychiatry. 29(3). 624–632. 7 indexed citations

10.

Vandeputte, Marthe M., Li Chen, Grant C. Glatfelter, et al.. (2023). Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide. Drug and Alcohol Dependence. 249. 109939–109939. 27 indexed citations

11.

Glatfelter, Grant C., Marthe M. Vandeputte, Li Chen, et al.. (2023). Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose. Psychopharmacology. 240(12). 2573–2584. 31 indexed citations

12.

Glatfelter, Grant C., Eline Pottie, John S. Partilla, et al.. (2022). Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice. ACS Pharmacology & Translational Science. 5(11). 1181–1196. 56 indexed citations

13.

Vandeputte, Marthe M., Alex J. Krotulski, Donna Walther, et al.. (2022). Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid. Archives of Toxicology. 96(6). 1845–1863. 61 indexed citations

14.

Vandeputte, Marthe M., Nick Verougstraete, Donna Walther, et al.. (2022). First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass. Archives of Toxicology. 96(6). 1865–1880. 34 indexed citations

15.

Walton, Sara E., Alex J. Krotulski, Grant C. Glatfelter, et al.. (2022). Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats. Psychopharmacology. 240(1). 185–198. 26 indexed citations

16.

Glatfelter, Grant C., et al.. (2022). Methods to Assess Melatonin Receptor-Mediated Phase-Shift and Re-entrainment of Rhythmic Behaviors in Mouse Models. Methods in molecular biology. 2550. 391–411. 3 indexed citations

17.

Glatfelter, Grant C., John S. Partilla, & Michael H. Baumann. (2021). Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice. Neuropsychopharmacology. 47(4). 924–932. 16 indexed citations

18.

Rudin, Deborah, John D. McCorvy, Grant C. Glatfelter, et al.. (2021). (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice. Neuropsychopharmacology. 47(4). 914–923. 12 indexed citations

19.

Glatfelter, Grant C., Anthony Jones, Rajendram V. Rajnarayanan, & Margarita L. Dubocovich. (2020). Pharmacological Actions of Carbamate Insecticides at Mammalian Melatonin Receptors. Journal of Pharmacology and Experimental Therapeutics. 376(2). 306–321. 13 indexed citations

20.

Stein, Reed M., Hye Jin Kang, John D. McCorvy, et al.. (2020). Virtual discovery of melatonin receptor ligands to modulate circadian rhythms. Nature. 579(7800). 609–614. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact